VK

Vamshi Krishna Allamuneni

Active Director Director DIN 10709361
DIN 10709361 First appointment Jul 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Vamshi Krishna Allamuneni

Data last updated:

Vamshi Krishna Allamuneni is a Director at Amagi Healthcare Private Limited (since 2024). The company operates in Paper.

DIN 10709361
Primary Designation Director
Industry Paper
First Appointment 17 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amagi Healthcare Private Limited U21002TS2024PTC187596
Director17 Jul 20242024Active

Board colleagues of Vamshi Krishna Allamuneni

NameDINCompanyDesignation
Vijay Kumar Emmadishetty10709362Amagi Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amagi Healthcare Private Limited
Premium access

Shareholding and investment profile for Vamshi Krishna Allamuneni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vamshi Krishna Allamuneni

Vamshi Krishna Allamuneni currently holds 1 directorship: Amagi Healthcare Private Limited (Director, since 17 Jul 2024).

Vamshi Krishna Allamuneni was first appointed on 17 Jul 2024 as Director at Amagi Healthcare Private Limited.

The current boards of Vamshi Krishna Allamuneni's companies include Vijay Kumar Emmadishetty (Amagi Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available